Fintel reports that on November 10, 2025, Benchmark upgraded their outlook for Canopy Growth (NasdaqGS:CGC) from Sell to Hold. Analyst Price Forecast Suggests 109.89% Upside As of November 9, 2025, ...

Acreage posted $39.6M in Q3 2024 revenue, down 30% YoY, with a net loss of $22.2M due to liquidity issues. Acreage launched non-medical cannabis sales in Ohio, representing 38% of Q3 2024 Ohio revenue ...

Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Canopy Growth Corporation ( TSE:WEED ) shareholders are probably feeling a little disappointed, since its shares ...

Canopy Growth has expanded its Spectrum Therapeutics portfolio in Australia by introducing new softgel capsules, enhancing its medical cannabis offerings in the region. This expansion strengthens ...

The Canadian marijuana player reported better-than-expected Q1 financials for fiscal 2026, driven by an over 20% YoY increase ...

An inner-eastern council has warned that a state government plan to fast-track housing will reduce tree cover so ...

Canopy Growth Corp's , chief David Klein expects the world's largest pot producer to become profitable in fiscal 2022, after ...